gvtcx

NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B

NHS England Published 7 Nov 2018 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£192,000,000
Statuscomplete
Category (CPV) 33141530
RegionScotland, Wales, Northern Ireland
Deadline11 Dec 2018
Contract start1 Mar 2019
Contract end28 Feb 2021
Procedureopen
SME suitableYes
OCIDocds-b5fd17-e9aa86d5-034f-4ac0-957f-a4479ae257f5

Awards (6)

This procurement was awarded to 5 suppliers. Values shown are per-award; the notice total is £192,000,000.

SupplierValueDateStatus
CSL Behring UK Limited shared £192,000,000 15 Feb 2019 active
Novo Nordisk Ltd shared £192,000,000 15 Feb 2019 active
Pfizer Ltd shared £192,000,000 15 Feb 2019 active
Shire Pharmaceuticals Ltd shared £192,000,000 15 Feb 2019 active
Swedish Orphan Biovitrum Ltd (Sobi UK Ltd) shared £192,000,000 15 Feb 2019 active
Swedish Orphan Biovitrum Ltd (Sobi UK Ltd) shared £0 15 Feb 2019 active

description

NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B. The framework will commence on 1st March 2019 for a period of 24 months until 28th February 2021, with options to extend up to a further 24 month.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
25 Mar 2019 Award update (awardUpdate) · 4b4175f9-e4ff-4ca9-a23b-79d639ae18c9-275483

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.